GoodRx’s brand new CEO, Wendy Barnes, says her job is not so much to fix anything, but to speed up the company’s current ...
As a reminder, today's call is being recorded. I would now like to introduce your host for today's call, Aubrey Reynolds, ...
Hosted on MSN15d
GoodRx (NASDAQ:GDRX) Misses Q4 Revenue EstimatesHealthcare tech company GoodRx (NASDAQ:GDRX) in Q4 CY2024, with sales flat year on year at $198.6 million. On the other hand, ...
GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today released a new report, The Prescription ...
Aigen Investment Management LP acquired a new stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX – Free Report) during the ...
Wells Fargo lowered the firm’s price target on GoodRx (GDRX) to $8 from $9 and keeps an Overweight rating on the shares. The firm says that ...
Morgan Stanley analyst Craig Hettenbach maintained a Hold rating on GoodRx Holdings (GDRX – Research Report) today and set a price target of ...
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth-quarter and full-year 2024 earnings call. As a reminder, today's call is being recorded. I would now like to ...
Women Spent $8.8 Billion More than Men in 2024, with Women Ages 18-44 Facing the Steepest Out-of-Pocket Cost Disparity GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S ...
Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2024 Earnings Call. As a reminder, today's call is being recorded. I would now like to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results